We can post all day long the benefits of Afrezza and the superiority of it over Exubera. We know there is very little comparson. The concern is that the medical profession does not. Should we be concerned at this point that 6 out of 75 doctors are not aware of Afrezza? I'm not sure, but it is obvious that this revelotionary drug will need mass marketing and a skilled and professional sales force to bring it to market. I would hope the marketing effort is also directed to the public through mass media to drive consumer demand. Some here may not want a partner, but I fail to see how Afrezza can take on a life of it's own in a short period of time without one.